Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 31

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06497036Phase 3Active Not Recruiting
Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia
Drug EffectImmunogenicitySafety Issues
PrincipalinvestigatorStart date: 2023-04-04

Research Network

Collaboration Network

6 collaborators·15 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

National Medical Research Center VA Almazov Ministry of Health of the Russian Federation

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Dmitry Kirtbaya

Oncological dispensary No. 2 of the Ministry of Health of the Krasnodar Territory

Moderately Similar
1 trials

Shared therapeutic areas:

Drug EffectImmunogenicitySafety Issues

Worked with same sponsors:

GeropharmI.M. Sechenov First Moscow State Medical University+1 more
Collaborated on 1 trial
Similarity Score34%

Elena Borisenkova

Kaluga Regional Clinical Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Drug EffectImmunogenicitySafety Issues

Worked with same sponsors:

GeropharmI.M. Sechenov First Moscow State Medical University+1 more
Collaborated on 1 trial
Similarity Score34%

Igor Davydkin

Samara State Medical University of the Ministry of Health of the Russian Federation

Moderately Similar
1 trials

Shared therapeutic areas:

Drug EffectImmunogenicitySafety Issues

Worked with same sponsors:

GeropharmI.M. Sechenov First Moscow State Medical University+1 more
Collaborated on 1 trial
Similarity Score34%

Olga Vinogradova

City Clinical Hospital named after S.P. Botkin of the Moscow City Health Department

Moderately Similar
1 trials

Shared therapeutic areas:

Drug EffectImmunogenicitySafety Issues

Worked with same sponsors:

GeropharmI.M. Sechenov First Moscow State Medical University+1 more
Collaborated on 1 trial
Similarity Score34%

Bulat Bakirov, MD

Bashkir State Medical University of the Ministry of Health of the Russian Federation

Moderately Similar
1 trials

Shared therapeutic areas:

Drug EffectImmunogenicitySafety Issues

Worked with same sponsors:

GeropharmI.M. Sechenov First Moscow State Medical University+1 more
Collaborated on 1 trial
Similarity Score34%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Safety Issues
Similarity Score10%

Tory Spindle, PhD

Johns Hopkins University

Related
7 trials

Shared therapeutic areas:

Drug Effect
Similarity Score10%

Qiang Li

Qingdao Haici Hospital

Related
1 trials

Shared therapeutic areas:

Safety Issues
Similarity Score10%

Helen McShane, Professor

University of Oxford

Related
4 trials

Shared therapeutic areas:

Immunogenicity
Similarity Score10%

Jin-Tae Kim, M.D., Ph.D.

Seoul National University Hospital

Related
5 trials

Shared therapeutic areas:

Drug Effect
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06497036Phase 3PrincipalInvestigator

Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia

Drug EffectImmunogenicitySafety Issues
Active Not Recruiting

All 1 trials loaded